Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 100%High 0 · 0%

Polyclonal T‐cell antibody induction vs interleukin‐2 receptor antagonist induction

Acute rejection · lung transplant recipients

Polyclonal T‐cell antibody induction showed no clear difference in acute rejection compared with interleukin‐2 receptor antagonist induction (moderate certainty).

1 finding from 1 review

Antibody induction therapy for lung transplant recipients 2013 · Cochrane Headline outcomes only
RR 1.33 [0.93, 1.92]
2 studies · 76 participants
Moderate

Polyclonal T‐cell antibody vs no antibody induction

Acute rejection grade II or higher · lung transplant recipients

Polyclonal T‐cell antibody showed no clear difference in acute rejection grade II or higher compared with no antibody induction (moderate certainty).

1 finding from 1 review

Antibody induction therapy for lung transplant recipients 2013 · Cochrane Headline outcomes only
RR 0.68 [0.44, 1.04]
3 studies · 125 participants
Moderate